NTT Com Launches Renewed SkyWay SDK for More Versatile Development of Online Communication Services
31.1.2023 13:01:00 EET | Business Wire | Press release
NTT Communications Corporation (NTT Com), the ICT solutions and international communications business within the NTT group, announced today the immediate launch of the renewed SkyWay software development kit (SDK). The new SkyWay SDK makes it easier than ever to implement real-time voice, video and data communication for applications and websites.
People interested planning or developing online communication services may apply to attend a free webinar in person (50 people) or online (100 people) to learn about the renewed SkyWay SDK at NTT Communications' Tokyo headquarters from 3:00pm (JST) on February 23.
Simple to use and supported with extensive documentation, SkyWay does not require special technical skills or knowledge of voice/video communication or constructing servers, and can be used for a wide range of applications, such as online lessons, IoT and robots. To date, SkyWay has been deployed for the development of more than 20,000 services.
SkyWay is suitable for diverse call formats including voice and video, one-to-one and group calls, and video communication while sharing screens. It also is a multiplatform SDK for developing communication services suited to specific industries and business categories. SkyWay assures high-quality real-time communication, as evidenced by its service uptime rate of 99.96% in fiscal 2021. It also achieves high-quality overseas calls by setting up servers to relay communications to/from Asia, North America and Europe.1 What's more, SkyWay may be used at no charge for service verification and development until the users service is actually launched. Furthermore, fees are adjusted to the scale of service and billing is implemented on a pay-as-you-go billing basis.
Due to the COVID-19 pandemic, online communication has rapidly diversified and now commonly includes events involving dozens of people as well as communication robots. In response, NTT Com decided to upgrade SkyWay's architecture and release it as a new service with enhanced functions for increased versatility, including:
- More simultaneous callers (expanded from 20 to 100 max.)
- Terminal load reduction according to end-user environment (simulcasting2 and API for flexible media transmission/reception, such as only specific video/audio)
- Authentication and authorization for controlling transmission of video/audio to each end user
The following are two examples of SkyWay's expanded functionality.
1. Virtual office
SkyWay can be used to create a system for an office-wide presentation reaching up to 100 people, with simulcasting allowing people to receive audio/video suitably adjusted to each user, such as low-resolution video to reduce system and battery load for mobile devices or terminals with low processing power. Also, participation can be controlled for private conferences.
2. Remote work support
SkyWay also can be used to create a system that allows a supervisor to remotely instruct multiple people at a worksite, using video for detailed directions and only audio if simple verbal directions are sufficient. Selective use of video and/or audio enables the system to reach many people with minimum load.
Service applications will be accepted from January 31. For details, please visit the website or contact a NTT Com sales representative, and for service rates, please see here. (Partially in Japanese only)
Looking ahead, NTT Com expects to further upgrade SkyWay by expanding the scale of voice and video calls, enhancing data communications for synchronization of more people, and supporting gaming platforms for live streaming and the metaverse. In addition, voice and video call experiences will be improved. Also, new SkyWay functions for measuring quality and analyzing problems will increasingly upgrade video and voice in diverse environments. Going forward, NTT Com will continue to develop SkyWay-related business to support the further evolution of real-time communication and its easy implementation by nonexperts in a world where people communicate meaningfully through the power of digital technology.
For more information about SkyWay, please visit here.
1 Technology that enables a terminal to select the most appropriate relay device in order to minimize delay between terminals (granted patent No. 6254620).
2 Technology for transmitting the same video to different terminals using different bitrates, such as low-resolution to mobile devices with limited processing power and bandwidth and high-resolution to PCs.
About NTT Communications
NTT Communications solves global technology challenges by helping enterprises utilize managed IT-infrastructure solutions to overcome complexity and risk in their IT environments. These solutions are backed by our worldwide infrastructure, including industry-leading, global tier-1 public and private networks reaching over 190 countries/regions, and more than 500,000m2 of the world's most advanced data-center facilities. As the core provider of the DOCOMO group's enterprise-business services and solutions, we create value by providing global-scale support for restructuring in industry and society, new workstyles and digital transformation in communities. Together with NTT Ltd., NTT Data and NTT DOCOMO, we are the NTT Group.
www.ntt.com | Twitter@NTT Com | Facebook@NTT Com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230130005787/en/
Contact information
For more information
SkyWay Promotion Office
Platform Service Division
NTT Communications Corporation
E-mail: skyway@ntt.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FPT Named an OpenAI Select Partner6.8.2026 03:00:00 EEST | Press release
Global IT corporation FPT today announced that it has been named an OpenAI Select Partner within the OpenAI Partner Network. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805503787/en/ FPT Named an OpenAI Select Partner The OpenAI Partner Network is a global program for partners to build, sell, and deliver AI solutions with OpenAI. It brings together partners with deep industry expertise, delivery capabilities, and customer relationships while equipping them with resources, enablement, and support to help enterprises adopt OpenAI frontier models and products and turn them into measurable impact. As an OpenAI Select Partner, FPT will continue working with OpenAI to help organizations build, deploy, and scale AI solutions responsibly and effectively. This work will help organizations get more useful work from every token and stronger performance per dollar with GPT‑5.6, while using ChatGPT Work to turn ambitious goals into
U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 01:10:00 EEST | Press release
Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of ORZEYFUL marks a new chapter for the narcolepsy type 1 community, as we introduce an entirely new class of medicine that will potentially redefine how this disease is managed and howpeople feel on treatment,” said Julie Kim, president and chief executive officer of Takeda. “We are proud to have discovered and developed this orexin treatment innovation and will bring it to adults living with NT1 as quickly as possible.” NT1 is a rare, chronic neurological disease d
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 23:30:00 EEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted
Clinilabs Announces Medical Leadership Appointments5.8.2026 17:05:00 EEST | Press release
Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership, and operational excellence with a track record of execution from first-in-human studies through regulatory
Interactive Brokers Adds Brazilian Futures through Brazil’s B3 Exchange5.8.2026 17:00:00 EEST | Press release
Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced that eligible clients outside of Brazil can now trade Brazilian futures in addition to equities through the B3 exchange. Interactive Brokers was the first broker to provide international investors with streamlined, low-cost access to B3. Offering Brazilian futures and equities alongside products across more than 170 markets worldwide underscores IBKR’s commitment to broadening global market access and giving clients efficient, cost-effective ways to diversify through a single, unified platform. Access to B3 provides exposure to one of Latin America’s most active and liquid markets, providing long-term growth potential across multiple sectors and another way for investors to pursue emerging market opportunities. "Global investors deserve seamless, low-cost access to the world's most compelling markets, including emerging economies shaping tomorrow's financial landscape," said Milan Galik, Chief Executive Off
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom